Diabetes mellitus and hypertension: key risk factors for kidney disease.

Janice P. Lea, Susanne B. Nicholas(University of California, Los Angeles)

PubMed

August 1, 2002

Cited by 167

Related Papers

Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial

|The Lancet|2018|775

Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial

|The Lancet|2017|734

MYH9 is associated with nondiabetic end-stage renal disease in African Americans

|Nature Genetics|2008|646

Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial

|The Lancet|2020|586

Predictors of blood pressure response in the SYMPLICITY HTN-3 trial

|European Heart Journal|2014|540